Method for raising hdl cholesterol levels

Compounds which are PPAR delta agonists are described. These compounds are useful for raising high density lipoprotein (HDL) plasma levels in mammals and for preventing, halting or slowing the progression of atherosclerotic cardiovascular diseases and related conditions and disease events. PPAR delta agonists can be administered alone or in combination with additional active agents such as LDL-lowering agents


Year:
1997
Note:
Applicant(s): Merck & Co Inc [Us], Leibowitz Mark D, Berger Joel P, Moller David E, Auwerx Johan, Berger Gregory D
Patent number(s):
Laboratories:




 Record created 2009-04-21, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)